Jpmorgan Chase & CO Prime Medicine, Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 35,663 shares of PRME stock, worth $86,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,663
Previous 35,640
0.06%
Holding current value
$86,304
Previous $104,000
32.69%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PRME
# of Institutions
128Shares Held
57.7MCall Options Held
12.4KPut Options Held
107K-
Alphabet Inc. Mountain View, CA15.1MShares$36.5 Million2.67% of portfolio
-
Black Rock Inc. New York, NY5.11MShares$12.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.14MShares$10 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.64MShares$8.81 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.1MShares$7.49 Million0.07% of portfolio
About Prime Medicine, Inc.
- Ticker PRME
- Shares Outstandng 95,730,200
- Market Cap $232M